Introduction

Randil is Nicorandil 20mg; a Potassium channel opener with nitrate effects.

Randil relieves symptoms & improves prognosis in patients with angina.

Randil offers both hemodynamic and metabolic cardiovascular benefits.

Randil showed anti-ischemic & Cardioprotective benefits for a wide range of CAD patients with different risk factors.

Randil is recommended in ESC 2006 guidelines for the management of stable angina in Class I and Class IIa.

Randil's starting dose is half a tablet twice daily, and its usual maintenance dose is one tablet (20mg) twice daily.

For more details, you can follow these links:

Product insert         Mechanism         JCAD study        ESC guidelines

The Egyptian study (BMJ)    IONA study    IONA subgroup analysis

Cairo CME session 2

Have a look at the photos & presentation of Adwia's second CME meeting in Alsarayah boat, Cairo:

"Problem solving in Cardiovascular risk"

Chairpersons:
Prof. Dr Ezz Adin AlSawy (Azhar Univ.).
Prof. Dr Wafaa AlArosy (Cairo Univ.).
Speakers:
Prof. Dr Soliman Ghareeb (Cairo Univ.).
Prof. Dr Omar Awwad (Ain Shams Univ.).

You can download the PDF presentation HERE.

With the compliments of Adwia

Randil & Menia University, Tut hotel

Have a look at the photos & presentation of Adwia's meeting in Menia, Tut hotel.

"The unmet needs in the management of Angina"

Meeting panel:
Prof. Dr Naser Taha (Menia Univ.).
Prof. Dr Omar Awwad (Ain Shams Univ.).

You can download the PDF presentation HERE.

With the compliments of Adwia